Use access key #2 to skip to page content.
$0.17 -0.01 (-5.56%)
10/6/2008 3:58 PM

Critical Therapeutics, Inc. (CRTX)

CAPS Rating:
*****

A biopharmaceutical company focused on the development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases linked to the body's inflammatory response.

View All Commentary (CRTX)

Recs

2

Avatar spikenailz (< 20) Submitted: 7/26/07 10:42 AM : Outperform Start Price: $2.30 CRTX Score: -62.41

They have had huge success with their asthma meds and they have some new ones in late stages of trials. This company has no where to go but up.

Report this Post Replies: 0 | Reply

Featured Broker Partners